TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Relaunches Cannabis Oral Solution Across Ireland
October 04, 2022 07:00 ET | Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring...
brains.jpg
Brains Bioceutical Opens UK’s Largest EU GMP-Grade Licensed Cannabinoid Research and Commercial Production Facility
September 29, 2022 01:00 ET | Brains Bioceutical Corp
VANCOUVER, British Columbia and SANDWICH, United Kingdom, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains” or the “Company”), is pleased to announce the opening of its recently...
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Medical Receives Approval to Extend Market Authorization in Italy
September 22, 2022 07:00 ET | Tilray Brands, Inc.
LEAMINGTON, Ontario and CANTANHEDE, Portugal, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company...
TilrayBrands_Logo_FullColor_RBG_Horiz-01.png
Tilray Initiates Roundtable With German Regulators to Kick-Off Draft Legislation to Legalize Adult-Use Cannabis in Germany
September 06, 2022 09:00 ET | Tilray Brands, Inc.
BERLIN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced...
OptimiTM-03.jpg
Optimi Health Completes Expansion Of On-Site Analytical Laboratory
May 11, 2022 09:00 ET | Optimi Health Corp.
VANCOUVER, British Columbia, May 11, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that it has completed a...
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Receives Project Characterization Report and Engages EU GMP Consultancy
January 09, 2020 00:05 ET | Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a...
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Enters MOU for European Distribution
January 02, 2020 09:00 ET | Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based business focused on becoming a...
Isracann BioSciences Logo RGB@4x-100 LG.jpg
Isracann Enters MOU for European Distribution
January 02, 2020 00:05 ET | Isracann Biosciences Inc.
VANCOUVER, British Columbia, Jan. 02, 2020 (GLOBE NEWSWIRE) -- Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based business focused on becoming a...